Health technology assessment in the Philippines

Rosas-Valera, Madeleine De

doi:10.1017/s0266462309090680

Cited by 4 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…HTA has been introduced in the Philippines since 1999 to inform coverage decisions for medicines, medical devices and procedures under PhilHealth, the national insurance scheme 27 . In 2013, as the Department of Health (DOH) adopted economic evaluation as a tool for the development of the national formulary 28 , it sought technical support from HITAP.…”

Section: Hitap and Nice Experiencesmentioning

confidence: 99%

Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE

Tantivess

Chalkidou²,

Tritasavit

et al. 2017

F1000Res

View full text Add to dashboard Cite

Health Technology Assessment (HTA) is policy research that aims to inform priority setting and resource allocation. HTA is increasingly recognized as a useful policy tool in low- and middle-income countries (LMICs), where there is a substantial need for evidence to guide Universal Health Coverage policies, such as benefit coverage, quality improvement interventions and quality standards, all of which aim at improving the efficiency and equity of the healthcare system. The Health Intervention and Technology Assessment Program (HITAP), Thailand, and the National Institute for Health and Care Excellence (NICE), UK, are national HTA organizations providing technical support to governments in LMICs to build up their priority setting capacity. This paper draws lessons from their capacity building programs in India, Colombia, Myanmar, the Philippines, and Vietnam. Such experiences suggest that it is not only technical capacity, for example analytical techniques for conducting economic evaluation, but also management, coordination and communication capacity that support the generation and use of HTA evidence in the respective settings. The learned lessons may help guide the development of HTA capacity in other LMICs.

show abstract

Section: Hitap and Nice Experiencesmentioning

confidence: 99%

Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE

Tantivess

Chalkidou²,

Tritasavit

et al. 2017

F1000Res

View full text Add to dashboard Cite

show abstract

“…Taiwan, South Korea, Thailand, and Singapore all now have agencies that systematically assess whether to subsidize a specific medicine. Other APAC countries, including Malaysia, Vietnam, the Philippines, China, and India, have begun to establish processes for value‐driven reimbursement decisions. Yet, in several countries, such as Cambodia, Laos, Indonesia, and Sri Lanka, no formal processes exist.…”

Section: Introductionmentioning

confidence: 99%

Beyond cost‐effectiveness: A five‐step framework for appraising the value of health technologies in Asia‐Pacific

Finkelstein

Krishnan

Doble

2019

Health Planning & Management

View full text Add to dashboard Cite

Summary Given resource constraints and the potential for increasingly high‐cost, cost‐effective medicines to become available, policymakers require strategies that go beyond cost‐effectiveness when making resource allocation decisions. This manuscript presents a five‐step framework that complements traditional health technology assessment (HTA) guidance documents that policymakers in Asia‐Pacific and elsewhere may consider when setting up HTA guidelines and/or evaluating whether or not to subsidize a medicine or other health innovations. The framework recommends that subsidy decisions be based on five criteria: the relative burden of the condition as compared with other conditions (step 1), comparative and cost‐effectiveness of the medicine (steps 2 and 3), the short‐term impact on the budget (step 4), and other considerations including patient and societal preferences (step 5). Our approach, which is a complement to traditional HTA guidance documents, is not prescriptive but provides an evidence‐based framework that HTA agencies in Asia‐Pacific can follow as they aim to deliver value‐based medicines to their constituents.

show abstract

“…Current literature includes many reports describing the implementation and promotion of HTA in health systems in some LMIC such as in Thailand (37), Malaysia (34), Philippines (9), China (6), Romania (7), Mexico (17), Brazil (4), Argentina (32), Lithuania (8), for instance. Some of these countries have effective HTA programs whereas efforts are being made in some others to establish HTA or HTA-related activities without a formal HTA program.…”

mentioning

confidence: 99%

Implementation of Local/Hospital-Based Health Technology Assessment Initiatives in Low- And Middle-Income Countries

Attieh

Gagnon²

2012

Int J Technol Assess Health Care

View full text Add to dashboard Cite

Currently, HTA plays an increasingly important role in healthcare systems in supporting decision making for healthcare policies and practices. This systematic review contributes to identify priorities in the process and methodology of HTA implementation at the local/hospital level in LMIC. The paucity of HTA in LMIC is often assumed to be due to the lack of formally tasked HTA agencies, to politics and to shortage of resources.

show abstract

Health technology assessment in the Philippines

Cited by 4 publications

References 0 publications

Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE

Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE

Beyond cost‐effectiveness: A five‐step framework for appraising the value of health technologies in Asia‐Pacific

Implementation of Local/Hospital-Based Health Technology Assessment Initiatives in Low- And Middle-Income Countries

Contact Info

Product

Resources

About